Cargando…

BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment

Butyrophilin-3A (BTN3A) subfamily members are a group of immunoglobulins present on the surface of different cell types, including innate and cancer cells. Due to their high similarity with the B7 family members, different studies have been conducted and revealed the involvement of BTN3A molecules i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kone, Abdou-samad, Ait Ssi, Saadia, Sahraoui, Souha, Badou, Abdallah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653866/ https://www.ncbi.nlm.nih.gov/pubmed/36362212 http://dx.doi.org/10.3390/ijms232113424

Ejemplares similares

Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades
por: Ait Ssi, Saadia, et al.
Publicado: (2021)

NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
por: Miftah, Hayat, et al.
Publicado: (2023)

A(2A)R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
por: Rafii, Soumaya, et al.
Publicado: (2023)

TMIGD2 as a potential therapeutic target in glioma patients
por: Boulhen, Chaimae, et al.
Publicado: (2023)

High VISTA expression is linked to a potent epithelial-mesenchymal transition and is positively correlated with PD1 in breast cancer
por: Rezouki, Ibtissam, et al.
Publicado: (2023)

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021)

New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
por: Blazquez, Juan-Luis, et al.
Publicado: (2018)

The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma
por: Lin, Yuansheng, et al.
Publicado: (2022)

Btn3 is a negative regulator of Btn2-mediated endosomal protein trafficking and prion curing in yeast
por: Kanneganti, Vydehi, et al.
Publicado: (2011)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
por: Ghouzlani, Amina, et al.
Publicado: (2021)

Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology
por: Vantourout, Pierre, et al.
Publicado: (2018)

Altered expression of Butyrophilin (BTN) and BTN‐like (BTNL) genes in intestinal inflammation and colon cancer
por: Lebrero‐Fernández, Cristina, et al.
Publicado: (2016)

Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
por: Fanale, Daniele, et al.
Publicado: (2021)

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
por: Bian, Benjamin, et al.
Publicado: (2019)

Prognostic and Therapeutic Significance of BTN3A Proteins in Tumors
por: Chen, Sihan, et al.
Publicado: (2021)

Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints
por: Girard, Pauline, et al.
Publicado: (2020)

Investigation of the intramolecular hydrogen bonding interactions and excited state proton transfer mechanism for both Br-BTN and CN-BTN systems
por: Yang, Dapeng, et al.
Publicado: (2019)

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
por: Fanale, Daniele, et al.
Publicado: (2022)

Reply to Herrmann: The BTN3A isoform BTN3A1 is responsible for phosphoantigen-induced Vγ9Vδ2 T cell activation
por: Zhou, Jiaqing, et al.
Publicado: (2023)

Caveat: Monoclonal antibodies 20.1 and 103.2 bind all human BTN3A proteins and are not suited to study BTN3A1-specific features
por: Herrmann, Thomas
Publicado: (2023)

Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
por: Guo, Xinyu, et al.
Publicado: (2023)

BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis
por: Le Page, Cécile, et al.
Publicado: (2012)

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma
por: Billon, Emilien, et al.
Publicado: (2021)

Immune Checkpoint in Glioblastoma: Promising and Challenging
por: Huang, Jing, et al.
Publicado: (2017)

Bioinformatics Training Network (BTN): a community resource for bioinformatics trainers
por: Schneider, Maria V., et al.
Publicado: (2012)

Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis?
por: Duitman, JanWillem, et al.
Publicado: (2019)

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis
por: Ye, Wenrui, et al.
Publicado: (2021)

BTN2A2, a new biomarker and therapeutic target for glioma
por: Wang, Heping, et al.
Publicado: (2023)

Btn2a2 Regulates ILC2–T Cell Cross Talk in Type 2 Immune Responses
por: Frech, Michael, et al.
Publicado: (2022)

The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer
por: Zohair, Basma, et al.
Publicado: (2023)

Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
por: Cheng, Xu, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognostic Value and Immune Infiltration of Butyrophilin Subfamily 2/3 (BTN2/3) Members in Pan-Glioma
por: He, Dong, et al.
Publicado: (2022)

Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes
por: Girard, Pauline, et al.
Publicado: (2021)

CRISPR/Cas9 in Leishmania mexicana: A case study of LmxBTN1
por: Ishemgulova, Aygul, et al.
Publicado: (2018)

Enhancement of nematicidal potential through cloning and expression of chitinase gene from Bacillus subtilis subsp. Subtilis BTN7A strain
por: Abdel-Salam, Mohamed S., et al.
Publicado: (2018)

Glioblastoma Following Treated Medulloblastoma After 29 Years in the Posterior Fossa: Case Report and Review of Literature
por: Mesbahi, Tarek, et al.
Publicado: (2022)

pH-dependent localization of Btn1p in the yeast model for Batten disease
por: Wolfe, Devin M., et al.
Publicado: (2011)

Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
por: Song, Yuxiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3dbn1ndjj26on4t2llrd63d07l